These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 903124)

  • 1. Biochemical factors in Schizophrenia.
    Snyder SH
    Hosp Pract; 1977 Oct; 12(10):133-40. PubMed ID: 903124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between epilepsy and schizophrenia: a biochemical hypothesis.
    Trimble M
    Biol Psychiatry; 1977 Apr; 12(2):299-304. PubMed ID: 15665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased dopamine-receptor sensitivity in schizophrenia.
    Owen F; Cross AJ; Crow TJ; Longden A; Poulter M; Riley GJ
    Lancet; 1978 Jul; 2(8083):223-6. PubMed ID: 79025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine and schizophrenia.
    Crow TJ; Johnstone EC; Longden A; Owen F
    Adv Biochem Psychopharmacol; 1978; 19():301-9. PubMed ID: 29450
    [No Abstract]   [Full Text] [Related]  

  • 5. The dopamine hypothesis of schizophrenia. A critical analysis.
    Luchins D
    Neuropsychobiology; 1975; 1(6):365-78. PubMed ID: 1234325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy of schizophrenia.
    Ban TA
    Curr Psychiatr Ther; 1976; 16():163-75. PubMed ID: 991627
    [No Abstract]   [Full Text] [Related]  

  • 7. Does dopamine have a role in schizophrenia?
    Carlsson A
    Biol Psychiatry; 1978 Feb; 13(1):3-21. PubMed ID: 341997
    [No Abstract]   [Full Text] [Related]  

  • 8. [Schizophrenia as a dopamine excess syndrome].
    Toru M
    Nihon Rinsho; 1983 May; 41(5):1021-7. PubMed ID: 6138444
    [No Abstract]   [Full Text] [Related]  

  • 9. The prolactin response in clinical psychiatry.
    Gruen PH
    Med Clin North Am; 1978 Mar; 62(2):409-24. PubMed ID: 347199
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopamine and schizophrenia.
    Westerink BH; Korf J
    Lancet; 1976 Dec; 2(7997):1249-50. PubMed ID: 63073
    [No Abstract]   [Full Text] [Related]  

  • 11. Does dopamine play a role in schizophrenia?
    Carlsson A
    Psychol Med; 1977 Nov; 7(4):583-97. PubMed ID: 22890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine and schizophrenia.
    Meltzer HY; Goode DJ; Fang VS; Schyve P; Young M
    Lancet; 1976 Nov; 2(7995):1142. PubMed ID: 62982
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
    Hornykiewicz O
    Annu Rev Pharmacol Toxicol; 1977; 17():545-59. PubMed ID: 17361
    [No Abstract]   [Full Text] [Related]  

  • 14. Brain dopamine and behaviour. A critical analysis of the relationship between dopamine antagonism and therapeutic efficacy of neuroleptic drugs.
    Crow TJ; Gillbe C
    J Psychiatr Res; 1974; 11():163-72. PubMed ID: 4461788
    [No Abstract]   [Full Text] [Related]  

  • 15. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).
    Marsden CD
    Mod Trends Neurol; 1975; 6():141-66. PubMed ID: 127927
    [No Abstract]   [Full Text] [Related]  

  • 16. Mayo Seminars in Psychiatry: dopamine and schizophrenia--a review.
    Fredrickson P; Richelson E
    J Clin Psychiatry; 1979 Sep; 40(9):399-405. PubMed ID: 39063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology and physiology of stereotyped behavior.
    Randrup A; Munkvad I
    J Psychiatr Res; 1974; 11():1-10. PubMed ID: 4218871
    [No Abstract]   [Full Text] [Related]  

  • 18. [Schizophrenia and dopamine (author's transl)].
    Toru M
    Tanpakushitsu Kakusan Koso; 1978; 23(4):303-16. PubMed ID: 26107
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical aspects of schizophrenia.
    Lewis ME
    Essays Neurochem Neuropharmacol; 1980; 4():1-67. PubMed ID: 6104597
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
    Hornykiewicz O
    Neuroscience; 1978; 3(9):773-83. PubMed ID: 30919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.